Jin Wei Wu
Directeur/Membre du Conseil chez Taizhou Juhe Investment Co. Ltd.
Profil
Jin Wei Wu is currently an Executive Director at Taizhou Juhe Investment Co. Ltd.
Previously, Wu held positions as Director & Deputy General Manager at Zhejiang Starry Pharmaceutical Co., Ltd.
and as General Manager & Executive Director at Shanghai Starry Pharmaceutical Co., Ltd.
Postes actifs de Jin Wei Wu
Sociétés | Poste | Début |
---|---|---|
Taizhou Juhe Investment Co. Ltd.
Taizhou Juhe Investment Co. Ltd. Financial ConglomeratesFinance Taizhou Juhe Investment Co. Ltd. is a private company that provides investment services. The company is based in Taizhou, China. and has subsidiaries in China. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jin Wei Wu
Sociétés | Poste | Fin |
---|---|---|
Shanghai Starry Pharmaceutical Co., Ltd.
Shanghai Starry Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Starry Pharmaceutical Co., Ltd. engages in development and production of non-ionic contrast agent diagnostic drug preparations. Its four production lines include high-volume injection, small-volume injection, cream (hormonal), and cream and gel. The company was founded on June 5, 2012 and is headquartered in Shanghai, China. | Directeur Général | 28/12/2016 |
ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
Taizhou Juhe Investment Co. Ltd.
Taizhou Juhe Investment Co. Ltd. Financial ConglomeratesFinance Taizhou Juhe Investment Co. Ltd. is a private company that provides investment services. The company is based in Taizhou, China. and has subsidiaries in China. | Finance |
Shanghai Starry Pharmaceutical Co., Ltd.
Shanghai Starry Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Starry Pharmaceutical Co., Ltd. engages in development and production of non-ionic contrast agent diagnostic drug preparations. Its four production lines include high-volume injection, small-volume injection, cream (hormonal), and cream and gel. The company was founded on June 5, 2012 and is headquartered in Shanghai, China. | Health Technology |